Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Researcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Safety for Home Administration of Microdose Psilocybin UseClinicalTrials.gov · 2026-08-14Psilocybin Administration With 5-HT1a BlockadeClinicalTrials.gov · 2026-08-14Effects of Psilocybin in Patients With Amyotrophic Lateral SclerosisClinicalTrials.gov · 2026-08-11A Phase III, Multicentre, Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy, Safety, and Tolerability of COMP360 in Participants With Treatment-resistant DepressionClinicalTrials.gov · 2026-08-10Feasibility and Tolerability of Psilocybin for Phantom Limb Pain.The journal of pain · 2026-08-07Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin (NECTAR) in Aging and Alzheimer's DiseaseClinicalTrials.gov · 2026-08-07Open Label Psilocybin Brain Stimulation and Imaging Pilot StudyClinicalTrials.gov · 2026-08-07Psilocybin and Affective Function in Chronic Lower Back Pain DepressionClinicalTrials.gov · 2026-07-24Effects of Psilocybin on Electrophysiology and the Dynamic Content of ThoughtClinicalTrials.gov · 2026-07-23A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Psilocybin in Adults With Major Depressive Disorder (MDD)ClinicalTrials.gov · 2026-07-23PRISMatic: A Phase 1b Randomized, Double-Armed, Parallel-Group, Placebo-Controlled Trial of Psilocybin Efficacy With or Without Pimavanserin PretreatmentClinicalTrials.gov · 2026-07-21Outpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder: a Randomized Double-blind TrialClinicalTrials.gov · 2026-07-175-HT2A Agonist Psilocybin in the Treatment of Tobacco Use DisorderClinicalTrials.gov · 2026-06-29Psilocybin for PTSD With or Without Psychotherapy: A Pilot Study of Safety and EfficacyClinicalTrials.gov · 2026-06-22A Randomized, Double-Blind Study of Single-Dose Psilocybin for Major Depressive Disorder (MDD)ClinicalTrials.gov · 2026-04-22Effects of Psilocybin in Obsessive Compulsive DisorderClinicalTrials.gov · 2026-04-02“You can only take your clients as far as you’ve been yourself”: examining the intersections between psychedelic-assisted therapy, lived-living experience, and clinical practiceDrugs Education Prevention and Policy · 2026-03-22Pilot Study of Psilocybin-assisted Treatment for Cannabis Use DisorderClinicalTrials.gov · 2026-03-18Pilot Study of Serotonin 2A Receptor (5-HT2A) Agonist Psilocybin for Depression in Patients With Mild Cognitive Impairment or Early Alzheimer's DiseaseClinicalTrials.gov · 2026-03-16Psilocybin Treatment of Major Depressive Disorder With Co-occurring Alcohol Use DisorderClinicalTrials.gov · 2026-03-13Inpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder: a Randomized Double-blind TrialClinicalTrials.gov · 2026-02-23Investigation of Psychedelic Effects in Psychoactive SubstancesClinicalTrials.gov · 2026-02-23Rebuttal to "Questioning the recovery of dissociated traumatic memories under psilocybin".Journal of eating disorders · 2026-02-17Psychedelic Healing: Adjunct Therapy Harnessing Opened MalleabilityClinicalTrials.gov · 2026-02-13Distinguishing 4- vs 5-Hydroxy- N, N -Dimethyltryptamine (Psilocin vs Bufotenine) Using Hydrogen-Deuterium Back-ExchangeJournal of the American Society for Mass Spectrometry · 2026-02-04The Safety and Efficacy of Psilocybin in Patients With Treatment-resistant Depression and Chronic Suicidal IdeationClinicalTrials.gov · 2025-12-24Psilocybin and MDMA for Post-traumatic Stress Disorder (PTSD)ClinicalTrials.gov · 2025-10-01PRoMiSS: Psilocybin and the Role of Music in Set and SettingClinicalTrials.gov · 2025-09-18Effects of Psilocybin in Post-Treatment Lyme DiseaseClinicalTrials.gov · 2025-08-20Therapeutic emergence of dissociated traumatic memories during psilocybin treatment for anorexia nervosa.Journal of eating disorders · 2025-05-26Psilocybin-facilitated Smoking Cessation Treatment: A Pilot StudyClinicalTrials.gov · 2025-05-25Psilocybin-gestützte Therapie von Depression, Angst und Suchtstörungen: Neurobiologische Grundlagen und klinische AnwendungNervenheilkunde · 2025-05-01ALSUntangled #77: Psilocybin.Amyotrophic lateral sclerosis & frontotemporal degeneration · 2025-05-01Precision Functional Mapping of Psilocybin’s Acute and Persistent Brain EffectsBiological Psychiatry · 2025-04-09Australian psychologists' attitudes towards psychedelic-assisted therapy and training following a world-first drug down-scheduling.Drug and alcohol review · 2025-01-01Chronic pain education: past, present, and future of psychedelics for the management of chronic painPain Medicine · 2024-12-10Efficacy and Safety of COMP360 Psilocybin Therapy in Anorexia Nervosa: a Proof-of-concept StudyClinicalTrials.gov · 2024-12-04The Afterglow Inventory (AGI) - validation of a new instrument for measuring subacute effects of classic serotonergic psychedelicsPsyArXiv · 2024-10-22An Open Label Study of the Safety and Efficacy of Psilocybin in Participants With Treatment-Resistant Depression (P-TRD)ClinicalTrials.gov · 2024-08-09Psilocybin desynchronizes the human brain.Nature · 2024-08-01From chaos to kaleidoscope: Exploring factors in psychedelic self-treatment for mental health conditionsJournal of Psychopharmacology · 2024-07-28Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocolWellcome Open Res · 2024-07-24Historical Perspectives and Pharmacodynamic Actions of the Magic Mushroom (Psilocybin) for Future Global HealthcareTrends in Medical Research · 2024-06-28Effects of Psilocybin-facilitated Experience on the Psychology and Effectiveness of Professional Leaders in ReligionClinicalTrials.gov · 2024-06-18[Psilocybin-Assisted Treatment of Depression, Anxiety and Substance use Disorders: Neurobiological Basis and Clinical Application].Fortschritte der Neurologie-Psychiatrie · 2024-06-01Long-COVID symptoms improved after MDMA and psilocybin therapy: A case report.Clinical case reports · 2024-06-01Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocol.Wellcome open research · 2024-01-01Domestication through clandestine cultivation constrained genetic diversity in magic mushrooms relative to naturalized populations.Current biology: CB · 2023-12-04The Altered Xperience Project (AXP): Quantitative and Qualitative Data from a Citizen Science Initiative on the Subjective Experience of Altered States of ConsciousnessPsyArXiv · 2023-06-04Effects of Psilocybin in Anorexia NervosaClinicalTrials.gov · 2023-05-06The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant DepressionClinicalTrials.gov · 2023-04-24Microdosing psilocybin for chronic pain: a case series.Pain · 2023-04-01Genome sequencing progenies of magic mushrooms (Psilocybe subaeruginosa) identifies tetrapolar mating and gene duplications in the psilocybin pathway.Fungal genetics and biology: FG & B · 2023-03-01The Safety and Efficacy of Psilocybin in Participants With Type 2 Bipolar Disorder (BP-II) Depression.ClinicalTrials.gov · 2022-10-25Phenomenological assessment of psychedelics induced experiences: Translation and validation of the German Challenging Experience Questionnaire (CEQ) and Ego-Dissolution Inventory (EDI).PloS one · 2022-01-01Effects of Psilocybin in Major Depressive DisorderClinicalTrials.gov · 2021-12-15Ethnoracial health disparities and the ethnopsychopharmacology of psychedelic-assisted psychotherapies.Experimental and clinical psychopharmacology · 2021-10-01Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice.Proceedings of the National Academy of Sciences of the United States of America · 2021-04-27Phenomenological assessment of psychedelic induced experiences: Translation and validation of the German Challenging Experience Questionnaire (CEQ) and Ego-Dissolution Inventory (EDI)PsyArXiv · 2021-04-02Dose-response relationships of psilocybin-induced subjective experiences in humans.Journal of psychopharmacology (Oxford, England) · 2021-04-01Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term MeditatorsClinicalTrials.gov · 2019-12-30Measurement of Persisting Changes in Emotional Brain Functioning Produced by PsilocybinClinicalTrials.gov · 2019-09-10Psychopharmacology of Psilocybin in Cancer PatientsClinicalTrials.gov · 2018-07-19Relief from intractable phantom pain by combining psilocybin and mirror visual-feedback (MVF).Neurocase · 2018-04-01[Psychotherapy with Adjuvant use of Serotonergic Psychoactive Substances: Possibilities and Challenges].Fortschritte der Neurologie-Psychiatrie · 2017-07-01Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA.The lancet. Psychiatry · 2016-05-01Effects of Psilocybin and Spiritual Practice on Persisting Changes in Attitudes and BehaviorClinicalTrials.gov · 2016-02-24Pilot Study: Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term MeditatorsClinicalTrials.gov · 2014-05-20Glucuronidation of Psilocin and 4-Hydroxyindole by the Human UDP-GlucuronosyltransferasesDrug Metabolism and Disposition · 2010-03-01Psilocybin Results Inspire ResearchersClinical Psychiatry News · 2007-07-01A new behavior change program using psilocybin.Psychotherapy · 1965-01-01